Twareat Medical Care Co. (9627.SR) — Cash flow
Operating, investing, and financing cash flow for Twareat Medical Care Co. — annual and quarterly.
| Metric (SAR Millions) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -10↓143.9% | 24↑66.0% | 14↓44.3% | 25 | |
| Depreciation & Amortization | 5↑30.4% | 4↑28.1% | 3↑100.8% | 2 | |
| Deferred Income Tax | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stock-Based Compensation | 0.00 | 0.00 | 0.00 | 0.00 | |
| Changes in Working Capital | -7↑70.5% | -22↓81.9% | -12↓192.1% | -4 | |
| Accounts Receivable | 0.13↑100.5% | -27↓90.4% | -14↓438.1% | -3 | |
| Inventory | 1↑832.4% | 0.12↑158.3% | -0.20↑77.6% | -0.91 | |
| Accounts Payable | -2↓141.4% | 5↑75.4% | 3↑29.8% | 2 | |
| Other Working Capital | -6↓1306.2% | -0.40↑44.6% | -0.73↑75.3% | -3 | |
| Other Non-Cash Items | 18↑419.4% | 3↓16.5% | 4↓50.1% | 8 | |
| Net Cash from Operating Activities | 6↓27.6% | 9↓6.0% | 9↓70.6% | 31 | |
| Operating Cash Flow | 6↓27.6% | 9↓6.0% | 9↓70.6% | 31 | |
| Investing Activities | |||||
| Investment in Property, Plant & Equipment | -13↓113.4% | -6↑23.9% | -8↑36.9% | -13 | |
| Capital Expenditure | -13↓111.3% | -6↑21.0% | -8↑39.0% | -13 | |
| Acquisitions | 0.00 | 0.00 | 0.00↓100.0% | 0.03 | |
| Purchases of Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Sales & Maturities of Investments | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Cash from Investing Activities | -13↓113.4% | -6↑23.9% | -8↑36.8% | -13 | |
| Financing Activities | |||||
| Net Debt Issuance | 19↑202.7% | 6↑372.9% | -2↑16.2% | -3 | |
| Long-Term Net Debt Issuance | -0.22↓2.5% | -0.21↑93.4% | -3↓307.7% | 2 | |
| Short-Term Net Debt Issuance | 19↑196.3% | 7↑647.4% | 0.88↑120.3% | -4 | |
| Net Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Common Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Share Buybacks | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Preferred Stock Issuance | 0.00 | 0.00 | 0.00 | 0.00 | |
| Dividends Paid | -10↓23.3% | -8↑1.6% | -8↓157.4% | -3 | |
| Common Dividends Paid | -10↓23.3% | -8↑1.6% | -8↓157.4% | -3 | |
| Preferred Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Other Financing Activities | -0.74↑0.0% | -0.74↑45.8% | -1↓108.7% | -0.66 | |
| Net Cash from Financing Activities | 8↑437.0% | -3↑79.0% | -12↓79.9% | -7 | |
| Cash Reconciliation | |||||
| Effect of Foreign Exchange | 0.00 | 0.00 | 0.00↓100.0% | 1 | |
| Net Change in Cash | 2↑11756.2% | 0.01↑100.1% | -11↓182.4% | 13 | |
| Cash at Beginning of Period | 2↑0.6% | 2↓82.4% | 13 | 0.00 | |
| Cash at End of Period | 4↑75.5% | 2↑0.6% | 2↓82.4% | 13 | |
| Income Taxes Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest Paid | 0.00 | 0.00 | 0.00 | 0.00 | |
| Free Cash Flow | -7↓357.8% | 3↑71.8% | 1↓92.0% | 19 | |
* All figures in Millions of SAR, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.